Cwa Asset Management Group, LLC Pfizer Inc Transaction History

Cwa Asset Management Group, LLC

$1.85 Billion
Q3 2024

A detailed history of Cwa Asset Management Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 47,742 shares of PFE stock, worth $1.23 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

47,742

Previous 43,647 9.38%

Holding current value

$1.23 Million

Previous $1.21 Million 14.04%

% of portfolio

0.07%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$27.7 - $31.39 $113,431 - $128,542	4,095 Added 9.38%	47,742 $1.38 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $3.36 Million - $3.85 Million	-129,644 Reduced 74.81%	43,647 $1.21 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $4.69 Million - $6.1 Million	-179,648 Reduced 50.9%	173,291 $4.99 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $387,550 - $453,008	-12,077 Reduced 3.31%	352,939 $11.7 Million
Q2 2023 Jul 27, 2023	BUY	$36.12 - $41.79 $588,719 - $681,135	16,299 Added 4.67%	365,016 $13.4 Million
Q1 2023 Apr 17, 2023	BUY	$39.39 - $51.28 $297,945 - $387,881	7,564 Added 2.22%	348,717 $14.2 Million
Q4 2022 Jan 09, 2023	BUY	$41.75 - $54.5 $588,883 - $768,722	14,105 Added 4.31%	341,153 $0
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $346,798 - $423,353	7,925 Added 2.48%	327,048 $14.3 Million
Q2 2022 Jul 21, 2022	BUY	$46.53 - $55.17 $394,574 - $467,841	8,480 Added 2.73%	319,123 $16.7 Million
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $3.62 Million - $4.49 Million	-79,126 Reduced 20.3%	310,643 $16.1 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $241,804 - $358,435	5,852 Added 1.52%	389,769 $23 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $2.77 Million - $3.56 Million	70,523 Added 22.5%	383,917 $16.5 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $976,105 - $1.11 Million	27,182 Added 9.5%	313,394 $12.4 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $1.3 Million - $1.47 Million	38,829 Added 15.7%	286,212 $10.4 Million
Q4 2020 Feb 23, 2021	BUY	$33.47 - $42.56 $247,544 - $314,773	7,396 Added 3.08%	247,383 $9.11 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $686,101 - $872,437	20,499 Added 9.34%	239,987 $8.83 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.33 Million - $1.56 Million	41,943 Added 23.62%	219,488 $8.06 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $222,556 - $269,994	-7,389 Reduced 4.0%	177,545 $5.81 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $946,914 - $1.35 Million	35,032 Added 23.37%	184,934 $6.04 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $172,171 - $195,392	5,230 Added 3.62%	149,902 $5.87 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $580,108 - $752,231	17,855 Added 14.08%	144,672 $5.2 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $398,940 - $447,917	10,788 Added 9.3%	126,817 $5.49 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $120,262 - $132,128	3,207 Added 2.84%	116,029 $4.93 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $122,219 - $139,343	3,177 Added 2.9%	112,822 $4.93 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $76,213 - $92,441	-2,211 Reduced 1.98%	109,645 $4.83 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $80,866 - $86,212	2,452 Added 2.24%	111,856 $4.06 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $655,495 - $760,464	20,542 Added 23.12%	109,404 $3.88 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $280,115 - $297,212	8,422 Added 10.47%	88,862 $3.22 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $167,152 - $184,136	5,392 Added 7.18%	80,440 $2.87 Million
Q2 2017 Aug 10, 2017	BUY	N/A	75,048	75,048 $2.52 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.

Account

Cwa Asset Management Group, LLC Pfizer Inc Transaction History